Walgreens Pharmacy - additional testing funding

The Centers for Disease Control and Prevention is forecasting a future opportunity for Walgreens Pharmacy to receive additional funding for testing services under NAICS code 456110, which classifies the pharmacy and drug store sector. This initiative is intended to support expanded testing capabilities, likely related to public health surveillance or disease prevention efforts, though specific testing parameters or volumes are not detailed. The opportunity is posted as a forecast with no solicitation number or set-aside designation, indicating it is a preliminary notice rather than a formal bid invitation. The point of contact for this opportunity is Holly Nickle, identified as the Program Point of Contact, with email ubf6@cdc.gov, while the Contracting Officer position is listed as “To Be Determined.” No specific office address or place of performance is provided, suggesting that services may be required across multiple Walgreens locations or statewide without geographic restrictions. The posting date indicates this forecast is planned for 2026, allowing potential vendors time to prepare. Interested parties are encouraged to monitor the federal opportunity portal at the provided link for updates or formal solicitations as the opportunity matures.